James D. Flaherty MD, MS, FACC, FSCAI

Dr. James D. Flaherty is a board-certified interventional cardiologist with more than two decades of experience in cardiovascular medicine, cardiac critical care, and clinical research. He has served as a principal investigator or co-investigator in more than 70 clinical trials and registries and is currently a Principal Investigator at Flourish Research in Chicago, at our Ravenswood site.

His research focuses on structural heart disease, including transcatheter aortic, mitral, and tricuspid valve therapies, as well as complex coronary intervention, heart failure device therapy, cardiogenic shock, and pulmonary embolism. He has contributed to major trials including the PARTNER trials, REDUCE LAP-HF II, TETONIC CAD, REPAIR-MR and PLATO trials, and serves as a national co-principal investigator of the Transpacific TAVR Registry. Dr. Flaherty has published extensively in journals including the Journal of the American College of Cardiology, Circulation, JAMA, JACC CV Interventions, JACC Asia and the American Journal of Cardiology.

Dr. Flaherty earned his BS in mathematics from the University of Notre Dame and his MS in natural sciences and biophysics and his MD with honors from the Jacobs School of Medicine of the State University of New York at Buffalo. He completed his residency in internal medicine and fellowships in cardiovascular disease and interventional cardiology at Northwestern University Feinberg School of Medicine. He is board certified in cardiovascular disease, interventional cardiology, and advanced heart failure and transplant cardiology.

Before coming to Flourish, he was a Professor of Medicine at Northwestern University Feinberg School of Medicine, where he served as the director of the Coronary Care Unit for more than a decade and helped lead the cardiovascular quality program. Dr. Flaherty serves on the editorial board of the American Journal of Cardiology, is a board member and co-course director of TCT Asia Pacific and is a Fellow of the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.